Abstract
Post stroke depression or PSD is believed to occur in ten to forty percent of all patients who survive stroke. These mood disturbances overlap with primary major depressive disorder in terms of symptom profile, natural history and response to antidepressant medications. Cognitive changes, especially impairments in executive functions, are commonly encountered in PSD. This may be the result of disruption to fronto-thalamo-cortical circuits in PSD. Both functional limitations following stroke and biological mechanisms may play important roles in the pathophysiology of PSD. Antidepressants are clinically effective in managing these mood disturbances and may have an important role in the prophylaxis of depression following stroke. PSD provides a naturalistic model that facilitates the study of the clinical correlates and neurobiological mechanisms that may be relevant in the pathophysiology of vascular depression.
Keywords: stroke, depression, location, executive dysfunction, norepinephrine, serotonin, antidepressants, prophylaxis
Current Neuropharmacology
Title: The Clinical Neuroscience of Post Stroke Depression
Volume: 2 Issue: 4
Author(s): Ebrahim Haroon and Anand Kumar
Affiliation:
Keywords: stroke, depression, location, executive dysfunction, norepinephrine, serotonin, antidepressants, prophylaxis
Abstract: Post stroke depression or PSD is believed to occur in ten to forty percent of all patients who survive stroke. These mood disturbances overlap with primary major depressive disorder in terms of symptom profile, natural history and response to antidepressant medications. Cognitive changes, especially impairments in executive functions, are commonly encountered in PSD. This may be the result of disruption to fronto-thalamo-cortical circuits in PSD. Both functional limitations following stroke and biological mechanisms may play important roles in the pathophysiology of PSD. Antidepressants are clinically effective in managing these mood disturbances and may have an important role in the prophylaxis of depression following stroke. PSD provides a naturalistic model that facilitates the study of the clinical correlates and neurobiological mechanisms that may be relevant in the pathophysiology of vascular depression.
Export Options
About this article
Cite this article as:
Haroon Ebrahim and Kumar Anand, The Clinical Neuroscience of Post Stroke Depression, Current Neuropharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570159043359567
DOI https://dx.doi.org/10.2174/1570159043359567 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biologics in Systemic Sclerosis
Current Pharmaceutical Biotechnology Animal Models in Neurology: Drawbacks and Opportunities
Current Pharmaceutical Design Disease Modification in Rheumatoid Arthritis and Osteoarthritis-Current and Emerging Targets and Therapeutics
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Inhibitory Effect of Copper on Cystathionine β-Synthase Activity: Protective Effect of an Analog of the Human Albumin N-Terminus
Protein & Peptide Letters Role of Vitamins in Human Health and Nutrition: Sources and Morbidity
Current Nutrition & Food Science Uric Acid and Oxidative Stress
Current Pharmaceutical Design Current Pharmacological Treatment of Pulmonary Arterial Hypertension
Current Clinical Pharmacology Effects of Static Magnetic Fields on Blood Pressure in Animals and Humans
Current Hypertension Reviews High Altitude Hypoxia
Current Proteomics The Mechanisms Responsible for Garlic - Drug Interactions and their In Vivo Relevance
Current Drug Metabolism Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Combination Secondary Prevention Therapies in Vascular Diseases
Vascular Disease Prevention (Discontinued) A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications
Current Diabetes Reviews Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Prognostic Value of Coronary Artery Calcification
Vascular Disease Prevention (Discontinued) Hypertension and Endothelial Dysfunction: Therapeutic Approach
Current Vascular Pharmacology Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design Expression and Function of Anti-Inflammatory Interleukins: The Other Side of the Vascular Response to Injury
Current Vascular Pharmacology Drugs of Abuse in Pregnancy, Poor Neonatal Development, and Future Neurodegeneration. Is Oxidative Stress the Culprit?
Current Pharmaceutical Design Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism
Current Vascular Pharmacology